A targeted therapy currently being investigated for treating certain types of cancer can overcome some of the limitations of standard…
Joana Carvalho
Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Joana Carvalho
Magnetic resonance spectroscopy (MRS) — a specialized imaging test to visualize and measure the amount of fat in certain…
The levels of a molecule known as CCL18 in the blood can be used in routine clinical practice to…
The U.S. Food and Drug Administration (FDA) has approved Avrobio‘s application to expand to the U.S. its ongoing Phase…
Gaucher disease is among the more costly of chronic diseases to treat in Iran, and efforts are needed to…
Cerdelga (eliglustat) has a favorable long-term safety profile consistent with previous observations among patients with type 1…
Although rare, aneurysms of the splenic artery are most likely underreported among patients with Gaucher disease, a case report…
The plant-based enzyme replacement therapy Elelyso (taliglucerase alfa) improves bone marrow response in adult patients with type 1 Gaucher disease,…